Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 5397-5402, October 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedman, H. S.
Right arrow Articles by Bigner, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedman, H. S.
Right arrow Articles by Bigner, D. D.

Melphalan Transport, Glutathione Levels, and Glutathione-S-transferase Activity in Human Medulloblastoma1

Henry S. Friedman2, Stephen X. Skapek, O. Michael Colvin, Gertrude B. Elion, M. Robert Blum, Paul M. Savina, John Hilton, S. Clifford Schold, Jr., Joanne Kurtzberg and Darell D. Bigner

Departments of Pediatrics [H. S. F., J. K., S. X. S.], Pathology [H. S. F., D. D. B.], and Medicine [G. B. E., S. C. S.], Duke University Medical Center, Durham, North Carolina 27710; The Johns Hopkins Oncology Center, Baltimore, Maryland 21205 [O. M. C., J. H.]; and Burroughs Wellcome Co., Research Triangle Park, North Carolina 27709 [M. R. B., P. M. S.]

Melphalan transport, glutathione levels, and glutathione-S-transferase activity were measured in two continuous human medulloblastoma cell lines and transplantable xenografts in athymic nude mice, TE-671 and Daoy. In vitro mean glutathione levels were 10.06 nmol/106 cells in TE-671 and 2.96 nmol/106 cells in Daoy. In vitro mean glutathione-S-transferase values were 91.52 nmol/min/mg protein in TE-671 and 50.31 nmol/min/mg protein in Daoy. Transport studies revealed kinetic parameters of Km = 108.3 µM, Vmax = 363.1 pmol/106 cells/min in TE-671 and Km = 111.7 µM, Vmax = 180.6 pmol/106 cells/min in Daoy. Melphalan transport was inhibited by both DL-{alpha}-2-aminobicyclo[2.2.1]heptane-2-carboxylic acid and sodium ion depletion in TE-671 and Daoy cells in vitro, indicating that both systems of amino acid transport are functional in these medulloblastoma lines. In vivo s.c. xenograft glutathione values were lower (7.79 nmol/mg protein) in TE-671 than in Daoy (13.68 nmol/mg protein). The mean plasma concentration in mice given a 10% lethal dose (71.3 mg/m2) of melphalan i.p. was 50.3 µM at 10 min, with the half-life of 29.9 min. At this dose, s.c. xenograft levels were 2- to 3-fold higher in TE-671 than in Daoy tumors for the 3-h period measured. These studies demonstrate transport parameters confirming facilitated transport of melphalan in human medulloblastoma, a mean murine plasma melphalan concentration (following treatment with melphalan) above the in vitro drug dose at which there is a 90% reduction in the number of colonies in comparison to controls for TE-671 and Daoy for 2 h, and glutathione and glutathione-S-transferase levels in the same range previously reported in other melphalan-sensitive and melphalan-resistant human tumors. Future work with spontaneous and acquired melphalan-resistant human medulloblastoma cell lines and xenografts will define the role of these mechanisms in mediating drug resistance.

1 This work was supported by NIH Grants CA11898, 1 NINCDS NS 20023, 1 K07 NS 00958, and CA44640, and by American Chemical Society Grant 403.

2 To whom requests for reprints should be addressed at Department of Pediatrics, Duke University Medical Center, Durham, NC 27710.

Received 3/17/88. Revised 6/17/88. Accepted 6/28/88.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
M. D. Bacolod, S. P. Johnson, F. Ali-Osman, P. Modrich, N. S. Bullock, O. M. Colvin, D. D. Bigner, and H. S. Friedman
Mechanisms of Resistance to 1,3-Bis(2-chloroethyl)-1-nitrosourea in Human Medulloblastoma and Rhabdomyosarcoma
Mol. Cancer Ther., July 1, 2002; 1(9): 727 - 736.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.